Data from ARROW Trial for Multiple Myeloma Progression-free survival with KYPROLIS
Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., discusses Data from ARROW Trial for Multiple Myeloma Progression-free survival with KYPROLIS at ASCO 2018.<br />
Author: Annual-Meeting
Added: 06/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Myeloma